293 related articles for article (PubMed ID: 18265478)
1. Obesity, metabolic syndrome, and prostate cancer.
Hsing AW; Sakoda LC; Chua S
Am J Clin Nutr; 2007 Sep; 86(3):s843-57. PubMed ID: 18265478
[TBL] [Abstract][Full Text] [Related]
2. Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer.
Hammarsten J; Högstedt B
Blood Press; 2004; 13(1):47-55. PubMed ID: 15083641
[TBL] [Abstract][Full Text] [Related]
3. Role of Metabolic Syndrome in Prostate Cancer Development.
Lifshitz K; Ber Y; Margel D
Eur Urol Focus; 2021 May; 7(3):508-512. PubMed ID: 33994167
[TBL] [Abstract][Full Text] [Related]
4. [Sex steroids and adipokines in men with prostate cancer and their relationship with obesity and metabolic syndrome].
Borowski A; Siemińska L
Wiad Lek; 2020; 73(1):180-187. PubMed ID: 32124831
[TBL] [Abstract][Full Text] [Related]
5. Obesity, adipokines, and prostate cancer (review).
Baillargeon J; Rose DP
Int J Oncol; 2006 Mar; 28(3):737-45. PubMed ID: 16465380
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer and metabolic syndrome: is there a link?
McGrowder DA; Jackson LA; Crawford TV
Asian Pac J Cancer Prev; 2012; 13(1):1-13. PubMed ID: 22502649
[TBL] [Abstract][Full Text] [Related]
7. Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway.
Martin RM; Vatten L; Gunnell D; Romundstad P; Nilsen TI
Cancer Causes Control; 2009 Sep; 20(7):1181-92. PubMed ID: 19277881
[TBL] [Abstract][Full Text] [Related]
8. Aromatase up-regulation, insulin and raised intracellular oestrogens in men, induce adiposity, metabolic syndrome and prostate disease, via aberrant ER-α and GPER signalling.
Williams G
Mol Cell Endocrinol; 2012 Apr; 351(2):269-78. PubMed ID: 22233684
[TBL] [Abstract][Full Text] [Related]
9. Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States.
Fesinmeyer MD; Gulati R; Zeliadt S; Weiss N; Kristal AR; Etzioni R
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):808-15. PubMed ID: 19258479
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome, obesity and cancer risk.
Belladelli F; Montorsi F; Martini A
Curr Opin Urol; 2022 Nov; 32(6):594-597. PubMed ID: 36081396
[TBL] [Abstract][Full Text] [Related]
11. Glucose impairments and insulin resistance in prostate cancer: the role of obesity, nutrition and exercise.
Di Sebastiano KM; Pinthus JH; Duivenvoorden WCM; Mourtzakis M
Obes Rev; 2018 Jul; 19(7):1008-1016. PubMed ID: 29573216
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Prostate Cancer according to Metabolic Health Status: a Nationwide Cohort Study.
Kim JW; Ahn ST; Oh MM; Moon DG; Han K; Park HS
J Korean Med Sci; 2019 Feb; 34(6):e49. PubMed ID: 30787682
[TBL] [Abstract][Full Text] [Related]
13. Obesity modulation - the role in carcinogenesis.
Legakis I; Syrigos K
Anticancer Agents Med Chem; 2010 Jul; 10(6):481-90. PubMed ID: 20698826
[TBL] [Abstract][Full Text] [Related]
14. Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer.
Albanes D; Weinstein SJ; Wright ME; Männistö S; Limburg PJ; Snyder K; Virtamo J
J Natl Cancer Inst; 2009 Sep; 101(18):1272-9. PubMed ID: 19700655
[TBL] [Abstract][Full Text] [Related]
15. Obesity, adipokines, and prostate cancer in a prospective population-based study.
Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
[TBL] [Abstract][Full Text] [Related]
16. The evolving role of diet in prostate cancer risk and progression.
Kaiser A; Haskins C; Siddiqui MM; Hussain A; D'Adamo C
Curr Opin Oncol; 2019 May; 31(3):222-229. PubMed ID: 30893147
[TBL] [Abstract][Full Text] [Related]
17. Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy.
Asmar R; Beebe-Dimmer JL; Korgavkar K; Keele GR; Cooney KA
Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):62-6. PubMed ID: 22907512
[TBL] [Abstract][Full Text] [Related]
18. The dysmetabolic syndrome: epidemiology and etiology.
Sauerwein HP
Nestle Nutr Workshop Ser Clin Perform Programme; 2006; 11():1-13. PubMed ID: 16820727
[TBL] [Abstract][Full Text] [Related]
19. Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome.
Dandona P; Dhindsa S; Chaudhuri A; Bhatia V; Topiwala S; Mohanty P
Curr Mol Med; 2008 Dec; 8(8):816-28. PubMed ID: 19075678
[TBL] [Abstract][Full Text] [Related]
20. Periprostatic adipose inflammation is associated with high-grade prostate cancer.
Gucalp A; Iyengar NM; Zhou XK; Giri DD; Falcone DJ; Wang H; Williams S; Krasne MD; Yaghnam I; Kunzel B; Morris PG; Jones LW; Pollak M; Laudone VP; Hudis CA; Scher HI; Scardino PT; Eastham JA; Dannenberg AJ
Prostate Cancer Prostatic Dis; 2017 Dec; 20(4):418-423. PubMed ID: 28653675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
